General information about company |
|||
|---|---|---|---|
| Scrip Code | 530715 | ||
| NSE Symbol | ALPSINDUS | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE093B01015 | ||
| Name of company | ALPS INDUSTRIES LIMITED | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2024 | ||
| Date of end of financial year | 31-Mar-2025 | ||
| Date of board meeting when results were approved | 27-Jun-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 21-Jun-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Half Yearly | ||
| Reporting Quarter | Yearly | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Audited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | ||
| Segment Reporting | Single segment | ||
| Description of single segment | Textile | ||
| Start date and time of board meeting | 27-Jun-2025 03:30:00 | ||
| End date and time of board meeting | 27-Jun-2025 07:10:00 | ||
| Whether cash flow statement is applicable on company | Yes | ||
| Type of cash flow statement | Cash Flow Indirect | ||
| Declaration of unmodified opinion or statement on impact of audit qualification | Statement on impact of audit qualification | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Oct-2024 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 0 | 0 | |
| Other income | 2728000 | 6604000 | |
| Total income | 2728000 | 6604000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | 0 |
| (b) | Purchases of stock-in-trade | 0 | 0 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | 0 |
| (d) | Employee benefit expense | 682000 | 2572000 |
| (e) | Finance costs | 161322000 | 633710000 |
| (f) | Depreciation, depletion and amortisation expense | 0 | 0 |
| (f) | Other Expenses | ||
| 1 | OTHER EXPENSES | 3302000 | 9174000 |
| Total other expenses | 3302000 | 9174000 | |
| Total expenses | 165306000 | 645456000 | |
| 3 | Total profit before exceptional items and tax | -162578000 | -638852000 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Total profit before tax | -162578000 | -638852000 |
| 6 | Tax expense | ||
| 7 | Current tax | 0 | 0 |
| 8 | Deferred tax | 0 | 0 |
| 9 | Total tax expenses | 0 | 0 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | -162578000 | -638852000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 |
| 16 | Total profit (loss) for period | -162578000 | -638852000 |
| 17 | Other comprehensive income net of taxes | 0 | 0 |
| 18 | Total Comprehensive Income for the period | -162578000 | -638852000 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | -162569000 | -638970000 | |
| Total profit or loss, attributable to non-controlling interests | -9000 | 118000 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | -162569000 | -638970000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | -9000 | 118000 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 391141000 | 391141000 | |
| Face value of equity share capital | 0 | 0 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 0 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -4.17 | -16.33 | |
| Diluted earnings (loss) per share from continuing operations | 0 | 0 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -4.17 | -16.33 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0 | 0 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 22260000 | ||
| Capital work-in-progress | 0 | ||
| Investment property | 12861000 | ||
| Goodwill | 0 | ||
| Other intangible assets | 0 | ||
| Intangible assets under development | 0 | ||
| Biological assets other than bearer plants | 0 | ||
| Investments accounted for using equity method | 0 | ||
| Non-current financial assets | |||
| Non-current investments | 0 | ||
| Trade receivables, non-current | 0 | ||
| Loans, non-current | 11000 | ||
| Other non-current financial assets | 0 | ||
| Total non-current financial assets | 11000 | ||
| Deferred tax assets (net) | 0 | ||
| Other non-current assets | 0 | ||
| Total non-current assets | 35132000 | ||
| 2 | Current assets | ||
| Inventories | 0 | ||
| Current financial asset | |||
| Current investments | 0 | ||
| Trade receivables, current | 0 | ||
| Cash and cash equivalents | 19237000 | ||
| Bank balance other than cash and cash equivalents | 75000000 | ||
| Loans, current | 0 | ||
| Other current financial assets | 431000 | ||
| Total current financial assets | 94668000 | ||
| Current tax assets (net) | 186000 | ||
| Other current assets | 10719000 | ||
| Total current assets | 105573000 | ||
| 3 | Non-current assets classified as held for sale | 0 | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0 | |
| Total assets | 140705000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 391141000 | ||
| Other equity | -9324137000 | ||
| Total equity attributable to owners of parent | -8932996000 | ||
| Non controlling interest | -3713000 | ||
| Total equity | -8936709000 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 4923133000 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other non-current financial liabilities | 0 | ||
| Total non-current financial liabilities | 4923133000 | ||
| Provisions, non-current | 227000 | ||
| Deferred tax liabilities (net) | 0 | ||
| Deferred government grants, Non-current | 0 | ||
| Other non-current liabilities | 0 | ||
| Total non-current liabilities | 4923360000 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 3993863000 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| Total Trade payable | 0 | ||
| Other current financial liabilities | 151034000 | ||
| Total current financial liabilities | 4144897000 | ||
| Other current liabilities | 5190000 | ||
| Provisions, current | 3967000 | ||
| Current tax liabilities (Net) | 0 | ||
| Deferred government grants, Current | 0 | ||
| Total current liabilities | 4154054000 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0 | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0 | |
| Total liabilities | 9077414000 | ||
| Total equity and liabilites | 140705000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Oct-2024 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether accounts are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Oct-2024 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| Total Amount of items that will not be reclassified to profit and loss | |||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0 | 0 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0 | 0 |
| 5 | Total Other comprehensive income | 0 | 0 |
Cash flow statement, indirect |
||||||
|---|---|---|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | |||||
| A | Date of start of reporting period | 01-Apr-2024 | ||||
| B | Date of end of reporting period | 31-Mar-2025 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | -638852000 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 633710000 | |||||
| Adjustments for decrease (increase) in inventories | 0 | |||||
| Adjustments for decrease (increase) in trade receivables, current | 0 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | 1654000 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0 | |||||
| Adjustments for other financial assets, non-current | 0 | |||||
| Adjustments for other financial assets, current | -431000 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | 0 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 242000 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 0 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 108000 | |||||
| Adjustments for provisions, non-current | 0 | |||||
| Adjustments for other financial liabilities, current | 97462000 | |||||
| Adjustments for other financial liabilities, non-current | 449151000 | |||||
| Adjustments for unrealised foreign exchange losses gains | -35000 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 1412000 | |||||
| Adjustments for share-based payments | 0 | |||||
| Adjustments for fair value losses (gains) | 0 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | 0 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | 1180449000 | |||||
| Net cash flows from (used in) operations | 541597000 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | -251000 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 541848000 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 0 | |||||
| Purchase of property, plant and equipment | 0 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 0 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 1412000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | -75000000 | |||||
| Net cash flows from (used in) investing activities | -73588000 | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 184553000 | |||||
| Repayments of borrowings | 0 | |||||
| Payments of lease liabilities | 0 | |||||
| Dividends paid | 0 | |||||
| Interest paid | 633710000 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -449157000 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 19103000 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||||
| Net increase (decrease) in cash and cash equivalents | 19103000 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 135000 | |||||
| Cash and cash equivalents cash flow statement at end of period | 19238000 | |||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Statement on impact of audit qualification |
| Auditor's opinion | Qualified opinion |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | AS GOEL AND COMPANY | Yes | 31-Aug-2027 | ||
|---|---|---|---|---|---|
Financial details |
|||
| Sr. | Particulars | Audited Figures (as reported before adjusting for qualifications) | Adjusted Figures (audited figures after adjusting for qualifications) |
| 1 | Turnover / Total income | 6604000 | 6604000 |
| 2 | Total Expenditure | 645456000 | 21937181000 |
| 3 | Net Profit/(Loss) | -638852000 | -21930577000 |
| 4 | Earnings Per Share | -16.33 | -560.68 |
| 5 | Total Assets | 140705000 | 140705000 |
| 6 | Total Liabilities | 9077414000 | 30369140000 |
| 7 | Net Worth | -8936709000 | -30228435000 |
Audit qualification |
|||||||
|---|---|---|---|---|---|---|---|
| Sr. | Details of Audit Qualification | Type of Audit Qualification | Frequency of qualification | For Audit Qualification(s) where the impact is quantified by the auditor | For Audit Qualification(s) where the impact is not quantified by the auditor | ||
| Management's Views | (i) Management's estimation on the impact of audit qualification | (ii) If management is unable to estimate the impact, reasons for the same | Auditors' Comments on (i) or (ii) above | ||||
| 1 | Textual Information(1) | Qualified opinion | Since how long continuing | Textual Information(2) | Textual Information(3) | Textual Information(4) | Textual Information(5) |
Text Block |
|
|---|---|
| Textual Information(1) | Refertonoteno.37tothenotesonaccounts,theCompanyhasnotprovidedforitsliabilitytowardsinterestandpartofprincipalloan,waivedearlier,andimpactofretainedearningsintermsofdraftrehabilitationschemeandnowrevokedbyitsconsentedlendersamountingtoRs.212917.26lakh,accordinglythelossfortheyearandloanliabilitywouldhavebeenincreasedandshareholderfundwouldhavebeenreducedtothatextent |
| Textual Information(2) | Duringearlieryear,thelendershavingmorethan83percentofthesecureddebtsoftheCompanyrevokedtheirconsenttotheDRSsettlementschemecirculatedbyerstwhileHonbleBIFR,interaliacontainingtherestructuringofthedebtsoftheCompany,whichwaspartlyimplemented.TheCompanyobjectedtothesaidrevocationofconsentbeingunjustifiedandbeyondtermsoftheschemeandfurthersubmittedanofferforsettlement.Ms.EdelweissAssetsReconstructionCompanyLtd.,presentlyholdingmorethan99percentofthetotalsecureddebtoftheCompanyEARC,hadfiledanOAbeforetheDRTandfurtherundertheprovisionsofSARFAESIhasauctionedsecuredpropertiesandhaveadjustedpartoftheirdueswiththerealizationmadethereof.TheCompanywasindiscussionwithEARCforsettlementofitsbalanceduesandManagementoftheCompanywithanexpectationtogettherevisedsettlementrestructuringproposalapprovedfromlendersandaccordingly,theCompanywouldbemeetingitsrevisedfinancialobligationshoweverinthemeantimeEARChasfiledanapplicationUndersec.7oftheInsolvencyandBankruptcyCodeIBC,2016beforeHonbleNationalCompanyLawTribunal,AllahabadBenchNCLT.Videitsorderdated13.9.2024,HonbleNCLTshasadmittedtheabovepetitiontoinitiateInsolvencyproceeding,declaredMoratoriumagainstcompanyandappointedMr.HemantSharmahavingIBBIRegn.No.IBBIIPA002IPN0001520161710019asInterimResolutionProfessionalIRPinthematter.FurthertheCommitteeofCreditorsCoCinitsmeetingpassedtheresolutionforappointmentofMr.HemantSharmatocontinuetoactasResolutionProfessionalinthematterandthereuponhetookoverthemanagementandoperationsoftheCorporateDebtorintermsofSection23oftheCode.TheCompany,atpresent,isundertheCorporateInsolvencyResolutionProcessCIRPintermsofprovisionsofInsolvencyandBankruptcyCode,2016IBCtheCode.Further,resolutionplansforcompanywereinvitedundertheCIRPprocessagainstwhichprospectiveresolutionapplicantshavesubmittedtheirplanswhichwerepresentedtotheCoCforitsapprovalandincaseofapprovalaplanbytheCoC,theplanwillneedtobefiledwiththeHonbleNCLTforitsapproval.Thefutureprospectsofthecompany,assuch,wouldbedeterminedonthecompletionofCIRP.AspertheCodeitisrequiredthattheCompanybemanagedasagoingconcernduringtheCIRP.AlsotheBoardofDirectorsPowerSuspendedofthecompanyhaverecommendedtotheRPtocontinuewiththemaintenanceofthestatusofcompanyasGoingConcerninviewofaboveanditsexpectationtogettherevisedsettlementrestructuringproposalapprovedfromlendersandaccordingly,theCompanywouldbemeetingitsrevisedfinancialobligations.Inviewofabove,thefinancialstatementsoftheCompanyforthefinancialyearendedonMarch31,2025havebeenpreparedongoingconcernassumptionbasisandcontinuewiththeearlierconsentedrestructuringscheme.Hence,noprovisionconsiderednecessaryintheseaccountstowardsinterestonentiresecuredloansandpartofprincipalsecuredloanwaivedearlierandimpactonretainedearningsthereontotalingtoRs.212917.26Lakhasperprovisionsofearlierconsentedscheme,whichtheCompanycontinuestogiveeffect.Theimpact,arisinguponapprovaloftherevisedsettlementresolutionplan,willbegiveneffectinthefinancialstatementsoftheyearofapprovalbytheHonbleNCLT |
| Textual Information(3) | NOT APPLICABLE |
| Textual Information(4) | NOT APPLICABLE |
| Textual Information(5) | NOT APPLICABLE |
Signatories detail |
|
|---|---|
| Name of CEO / Managing director | SANDEEP AGARWAL |
| Name of CFO | JAMIL AHMED KHAN |
| Name of audit committee chairman | HEMANT SHARMA |
| Name of statutory auditor | AS GOEL &CO. |
| Name of other signatory, if any, with designation | |
| Place | GHAZIABAD |
| Date | 27-Jun-2025 |